|
⚲
|
| Keyboard |
| CHP II LP
✚
|
|
|---|---|
| CIK # | 0001114499, 0001412662 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001114499] | |
| 4 | [0001114499] | |
| SC 13G | [0001114499] | |
| 3 | [0001412662] | |
| 4 | [0001412662] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| CHP II LP | ATYR Pharma Inc | [2016-02-04] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Park John Joseph | |
| CHP II LP | |
| aTYR Pharma Inc | |
| Hull Brandon H | |
| CHP II Management LLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
aTYR Pharma Inc LIFE
Common Stock
|
2015-05-12 | Conversion | 1,758,158 | ||
|
aTYR Pharma Inc LIFE
Series A Redeemable Convertible Preferred Stock · derivative
|
2015-05-12 | Conversion | 2,400,000 | $0.00 | |
|
aTYR Pharma Inc LIFE
Series B Redeemable Convertible Preferred Stock · derivative
|
2015-05-12 | Conversion | 3,600,000 | $0.00 | |
|
aTYR Pharma Inc LIFE
Series D Redeemable Convertible Preferred Stock · derivative
|
2015-05-12 | Conversion | 1,536,787 | $0.00 | |
|
aTYR Pharma Inc LIFE
Series C Redeemable Convertible Preferred Stock · derivative
|
2015-05-12 | Conversion | 2,127,660 | $0.00 | |
|
aTYR Pharma Inc LIFE
Series B-2 Redeemable Convertible Preferred Stock · derivative
|
2015-05-12 | Conversion | 4,320,173 | $0.00 |